239 related articles for article (PubMed ID: 34920706)
21. Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI.
Chen Y; Wu B; Liu H; Wang D; Gu Y
J Transl Med; 2018 Nov; 16(1):325. PubMed ID: 30470241
[TBL] [Abstract][Full Text] [Related]
22. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders.
Xu XQ; Qian W; Hu H; Su GY; Liu H; Shi HB; Wu FY
Acta Radiol; 2019 Feb; 60(2):239-246. PubMed ID: 29804475
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
Kim BS; Kim SJ; Pak K
Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010
[TBL] [Abstract][Full Text] [Related]
24. Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast.
Li X; Jiang N; Zhang C; Luo X; Zhong P; Fang J
Cancer Imaging; 2021 Mar; 21(1):29. PubMed ID: 33712070
[TBL] [Abstract][Full Text] [Related]
25. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
[TBL] [Abstract][Full Text] [Related]
26. Warthin's tumor of parotid gland: Surgery or follow-up? Diagnostic value of a decisional algorithm with functional MRI.
Espinoza S; Felter A; Malinvaud D; Badoual C; Chatellier G; Siauve N; Halimi P
Diagn Interv Imaging; 2016 Jan; 97(1):37-43. PubMed ID: 25543869
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
Abdel Razek AA; Samir S; Ashmalla GA
J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
[TBL] [Abstract][Full Text] [Related]
28. Multimodality fMRI with perfusion, diffusion-weighted MRI and
Zhu L; Wang J; Shi H; Tao X
J Magn Reson Imaging; 2019 Feb; 49(2):423-432. PubMed ID: 30475438
[TBL] [Abstract][Full Text] [Related]
29. Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.
Kato H; Kanematsu M; Watanabe H; Kajita K; Mizuta K; Aoki M; Okuaki T
Eur Radiol; 2015 Nov; 25(11):3247-54. PubMed ID: 25921591
[TBL] [Abstract][Full Text] [Related]
30. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
[TBL] [Abstract][Full Text] [Related]
31. Histogram analysis of apparent diffusion coefficient at 3.0 T in urinary bladder lesions: correlation with pathologic findings.
Suo ST; Chen XX; Fan Y; Wu LM; Yao QY; Cao MQ; Liu Q; Xu JR
Acad Radiol; 2014 Aug; 21(8):1027-34. PubMed ID: 24833566
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of conventional ROI-based and volumetric histogram analysis derived from CT enhancement in differentiating malignant and benign renal tumors.
Zhu Q; Zou J; Ye J; Zhu W; Wu J; Chen W
Br J Radiol; 2022 Jul; 95(1135):20210801. PubMed ID: 35333594
[TBL] [Abstract][Full Text] [Related]
33. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
[TBL] [Abstract][Full Text] [Related]
34. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.
Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T
Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of diffusion-weighted MR imaging for differentiating between Warthin's tumor and oncocytoma of the parotid gland.
Kato H; Fujimoto K; Matsuo M; Mizuta K; Aoki M
Jpn J Radiol; 2017 Feb; 35(2):78-85. PubMed ID: 28074380
[TBL] [Abstract][Full Text] [Related]
36. Apparent diffusion coefficient histogram in the differentiation of benign and malignant testicular tumors.
Minh ND; Hung ND; Tuan TA; Hien MM; Tuan HX; Duc NM
Int J Med Sci; 2024; 21(2):200-206. PubMed ID: 38169660
[No Abstract] [Full Text] [Related]
37. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
[TBL] [Abstract][Full Text] [Related]
38. MRI-based texture analysis to differentiate the most common parotid tumours.
Sarioglu O; Sarioglu FC; Akdogan AI; Kucuk U; Arslan IB; Cukurova I; Pekcevik Y
Clin Radiol; 2020 Nov; 75(11):877.e15-877.e23. PubMed ID: 32703544
[TBL] [Abstract][Full Text] [Related]
39. Dynamic contrast-enhanced MR in the diagnosis of lympho-associated benign and malignant lesions in the parotid gland.
Zhu L; Zhang C; Hua Y; Yang J; Yu Q; Tao X; Zheng J
Dentomaxillofac Radiol; 2016; 45(4):20150343. PubMed ID: 26846712
[TBL] [Abstract][Full Text] [Related]
40. Differential diagnosis of thyroid nodules by DCE-MRI based on compressed sensing volumetric interpolated breath-hold examination: A feasibility study.
Huang J; Liu D; Chen J; Wang X; Tang L; Zhang J; Tan Y; Lan X; Yin T; Nickel D; Wu J; Zhang J
Magn Reson Imaging; 2024 Sep; 111():138-147. PubMed ID: 38729225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
